恩卡因是一种Ic类抗失律剂,它阻断了冠状动脉光滑肌细胞中的电压依赖通道
Hongliang Li1,2, Yue Zhou1, Yongqi Yang1
1Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
恩卡因是一种抗失律药物,以度依赖的方式抑制血管 (Kv) 通道. 这一动作主要涉及KV1.5通道,改变了通道激活,而不依赖于使用.
科学领域:
- 心血管药理学心血管药理学
- 离子通道生理学 离子通道生理学
- 顺肌细胞生物学 顺肌细胞生物学
背景情况:
- 电压依赖 (Kv) 通道对于调节光滑肌细胞中的血管度至关重要.
- 了解药物如何影响这些通道是开发新型心血管治疗的关键.
研究的目的:
- 为了研究子冠状动脉光滑肌中的KV通道上的Encainide的抑制作用,这是一种C类的抗失常药物.
- 阐明参与 encainide 血管作用的机制和特定的 Kv 亚型.
主要方法:
- 血管光滑肌细胞中Kv电流的电生理记录.
- 度-反应分析以确定IC50和希尔系数.
- 使用列车脉冲评估使用依赖性的评估.
- 使用Kv1.5和Kv2.1抑制剂的亚型特定抑制研究.
主要成果:
- 恩凯尼德以度依赖的方式抑制了Kv通道 (IC50 = 8.91 ± 1.75 μM).
- 抑制涉及到激活曲线的转移,改变关属性,并且与使用无关.
- Kv1.5 抑制剂显著降低了该效应,但Kv2.1 抑制剂没有,确定Kv1.5 作为主要标.
结论:
- 恩卡因通过改变电压感应关,通过依赖度,使用独立的机制抑制血管KV通道.
- Kv1.5通道是主要的Kv亚型,它调解了 encainide 对血管光滑肌肉的抑制作用.
更多相关视频
07:19Recording of Inward Rectifying K+ Currents in Freshly Isolated Basilar Artery Smooth Muscle Cells by Patch Clamp Technique
Published on: February 7, 2025
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
